EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC 3.0

Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis

Juchul Hwang, Hyeyoung Hwang, Hyunjae Shin, Bo Hyun Kim, Seong Hee Kang, Jeong-Ju Yoo, Mi Young Choi, Dong Eun Lee, Dae Won Jun, Yuri Cho

Clinical and Molecular Hepatology · 01.07.2024 · 30 (3) · 561-576

DOI: 10.3350/cmh.2023.0384 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Clinical and Molecular Hepatology, erschienen am 01.07.2024. Verfasst von Juchul Hwang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Liver and Pancreatobiliary Cancer, National Cancer Center, Goyang, Korea. Hauptthemen laut MEDLINE: Obesity, Bariatric Surgery, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Korea Health Industry Development Institute, Ministry of Health and Welfare, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aims: Bariatric intervention has been reported to be an effective way to improve metabolic dysfunction-associated steatotic liver disease (MASLD) in obese individuals. The current systemic review aimed to assess the changes in MRI-determined hepatic proton density fat fraction (MRI-PDFF) and nonalcoholic fatty liver disease activity score (NAS) after bariatric surgery or intragastric balloon/gastric banding in MASLD patients with obesity.

Methods

We searched various databases including PubMed, OVID Medline, EMBASE, and Cochrane Library. Primary outcomes were the changes in intrahepatic fat on MRI-PDFF and histologic features of metabolic dysfunction-associated steatohepatitis (MASH).

Results

Thirty studies with a total of 3,134 patients were selected for meta-analysis. Bariatric intervention significantly reduced BMI (ratio of means, 0.79) and showed 72% reduction of intrahepatic fat on MRI-PDFF at 6 months after bariatric intervention (ratio of means, 0.28). Eight studies revealed that NAS was reduced by 60% at 3–6 months compared to baseline, 40% at 12–24 months, and 50% at 36–60 months. Nineteen studies revealed that the proportion of patients with steatosis decreased by 44% at 3–6 months, 37% at 12–24 months, and 29% at 36–60 months; lobular inflammation by 36% at 12–24 months and 51% at 36–60 months; ballooning degeneration by 38% at 12–24 months; significant fibrosis (≥F2) by 18% at 12–24 months and by 17% at 36–60 months after intervention.

Conclusions

Bariatric intervention significantly improved MRI-PDFF and histologic features of MASH in patients with obesity. Bariatric intervention might be the effective alternative treatment option for patients with MASLD who do not respond to lifestyle modification or medical treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ObesityBariatric SurgeryNon-alcoholic Fatty Liver DiseaseHumansMagnetic Resonance ImagingLiverFatty LiverBody Mass Index

Stichwörter der Autor:innen

Bariatric interventionMASHMRI-PDFFNASObesity

Autor:innen und Institutionen

  • Center for Liver and Pancreatobiliary Cancer, National Cancer Center, Goyang, Korea.
  • Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea.
  • Department of Gastroenterology and Hepatology, Soonchunhyang University Bucheon Hospital, Bucheon, Korea.
  • National Evidence-based Healthcare Collaborating Agency, Seoul, Korea.
  • Biostatistics Collaboration Team, Research Institute, National Cancer Center, Goyang, Korea.
  • Department of Internal Medicine, Hanyang University School of Medicine, Seoul, Korea.

Förderung

  • Korea Health Industry Development Institute
  • Ministry of Health and Welfare
  • National Research Foundation of Korea
  • National Cancer Center

Zitieren

APA

Hwang, J., Hwang, H., Shin, H., Kim, B. H., Kang, S. H., Yoo, J. J., Choi, M. Y., Lee, D. E., Jun, D. W., & Cho, Y. (2024). Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis. Clinical and Molecular Hepatology, 30(3), 561-576. https://doi.org/10.3350/cmh.2023.0384

Vancouver

Hwang J, Hwang H, Shin H, Kim BH, Kang SH, Yoo JJ, et al. Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis. Clinical and Molecular Hepatology. 2024;30(3):561-576. doi:10.3350/cmh.2023.0384

BibTeX
@article{Hwang2024,
  author = {Hwang, Juchul and Hwang, Hyeyoung and Shin, Hyunjae and Kim, Bo Hyun and Kang, Seong Hee and Yoo, Jeong-Ju and Choi, Mi Young and Lee, Dong Eun and Jun, Dae Won and Cho, Yuri},
  title = {Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis},
  journal = {Clinical and Molecular Hepatology},
  year = {2024},
  volume = {30},
  number = {3},
  pages = {561--576},
  doi = {10.3350/cmh.2023.0384}
}
Kostenlos starten →